Â¥
8.04
Dec 27
New Key Statistics Module, Z-Score and F-Score
SHSE:600223 Key Ratios
Market Cap ¥ M | 8,566.74 |
Enterprise Value ¥ M | 6,826.41 |
P/E(ttm) | 33.50 |
PE Ratio without NRI | 29.03 |
Forward PE Ratio | 22.15 |
Price/Book | 2.00 |
Price/Sales | 1.84 |
Price/Free Cash Flow | 102.96 |
Price/Owner Earnings | 117.93 |
Payout Ratio % | 0.36 |
Revenue (TTM) ¥ M | 3,986.00 |
EPS (TTM) ¥ | 0.24 |
Beneish M-Score | -3.16 |
10-y EBITDA Growth Rate % | 7.40 |
5-y EBITDA Growth Rate % | 0.50 |
y-y EBITDA Growth Rate % | -17.50 |
EV-to-EBIT | 19.10 |
EV-to-EBITDA | 19.10 |
PEG | 58.06 |
Shares Outstanding M | 1,016.57 |
Net Margin (%) | 5.93 |
Operating Margin % | 6.70 |
Pre-tax Margin (%) | 7.86 |
Quick Ratio | 2.96 |
Current Ratio | 3.45 |
ROA % (ttm) | 3.15 |
ROE % (ttm) | 5.86 |
ROIC % (ttm) | 5.69 |
Dividend Yield % | 1.77 |
Altman Z-Score | 5.18 |
SHSE:600223 Number of Guru Trades
SHSE:600223 Volume of Guru Trades
Gurus Latest Trades with SHSE:600223
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600223 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lushang Freda Pharmaceutical Co Ltd Insider Transactions
No Available Data